Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Korth

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Virus Research|April 25, 2006
Hijacking of the host-cell response and translational control during influenza virus infectionJohn C Kash, Alan G Goodman, Marcus J Korth, et al.
Deutsche Medizinische Wochenschrift (1946)|May 6, 1994
[Hepatocellular carcinoma following intravenous thorium X therapy]S Madeya, J Labenz, H Breining, et al.
Methods in Molecular Medicine|July 8, 2005
Virus infection and the interferon response: a global view through functional genomicsMarcus J Korth, John C Kash, Jeffrey C Furlong, et al.
Current Opinion in Immunology|September 10, 2013
Drug repurposing: a better approach for infectious disease drug discovery?G Lynn Law, Jennifer Tisoncik-Go, Marcus J Korth, et al.
Nature Reviews. Microbiology|June 4, 2013
Systems virology: host-directed approaches to viral pathogenesis and drug targetingG Lynn Law, Marcus J Korth, Arndt G Benecke, et al.
ILAR Journal|November 1, 2013
Old world monkeys and new age science: the evolution of nonhuman primate systems virologyRobert E Palermo, Jennifer Tisoncik-Go, Marcus J Korth, et al.
Journal of Virology|March 16, 2004
High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A proteinCarlos Coito, Deborah L Diamond, Petra Neddermann, et al.
Journal of Clinical Pharmacology|July 1, 1997
Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysisK Vadiei, S Troy, J Korth-Bradley, et al.
Clinical Pharmacology and Therapeutics|April 25, 2017
Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog AlfaJ A Abrantes, E I Nielsen, J Korth-Bradley, et al.
Journal of Clinical Pharmacology|November 8, 2001
Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in first relapseJ A Dowell, J Korth-Bradley, H Liu, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Virus Research|April 25, 2006
Hijacking of the host-cell response and translational control during influenza virus infectionJohn C Kash, Alan G Goodman, Marcus J Korth, et al.
Deutsche Medizinische Wochenschrift (1946)|May 6, 1994
[Hepatocellular carcinoma following intravenous thorium X therapy]S Madeya, J Labenz, H Breining, et al.
Methods in Molecular Medicine|July 8, 2005
Virus infection and the interferon response: a global view through functional genomicsMarcus J Korth, John C Kash, Jeffrey C Furlong, et al.
Current Opinion in Immunology|September 10, 2013
Drug repurposing: a better approach for infectious disease drug discovery?G Lynn Law, Jennifer Tisoncik-Go, Marcus J Korth, et al.
Nature Reviews. Microbiology|June 4, 2013
Systems virology: host-directed approaches to viral pathogenesis and drug targetingG Lynn Law, Marcus J Korth, Arndt G Benecke, et al.
ILAR Journal|November 1, 2013
Old world monkeys and new age science: the evolution of nonhuman primate systems virologyRobert E Palermo, Jennifer Tisoncik-Go, Marcus J Korth, et al.
Journal of Virology|March 16, 2004
High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A proteinCarlos Coito, Deborah L Diamond, Petra Neddermann, et al.
Journal of Clinical Pharmacology|July 1, 1997
Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysisK Vadiei, S Troy, J Korth-Bradley, et al.
Clinical Pharmacology and Therapeutics|April 25, 2017
Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog AlfaJ A Abrantes, E I Nielsen, J Korth-Bradley, et al.
Journal of Clinical Pharmacology|November 8, 2001
Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in first relapseJ A Dowell, J Korth-Bradley, H Liu, et al.
Pageof 8